CD4 and cancer: In previous studies, we reported that a subset of NY-ESO-1-specific CD4+ T cells directly recognizes NY-ESO-1-expressing cancer targets in a MHC class II-restricted manner (tumor-recognizing CD4+ T cells or TR-CD4 cells) [24, 29].